Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Shifting The PARADIGM: PrimeC, An Oral Candidate For Amyotrophic Lateral Sclerosis, Demonstrates Safety, Efficacy, And Target Engagement In An 18-Month Phase 2b Trial

              Author:Cudkowicz, Merit   Drory, Vivian   Chio, Adriano   Lunetta, Christian   Shoesmith, Christen   Zimri, Shiran   Russek-Blum, Niva   Shtossel, Diana   van Eijk, Ruben   Shapira, Guy   Shomron, Noam   Tracik, Ferenc   Rosenfeld, Jeffrey   Shefner, Jeremy   

              Session Name:S27: General Neurology 2  

              Topic:General Neurology  

              Program Number:S27.008  

              Author Institution:Massachusetts General Hospital, Boston, MA  Tel Aviv Sourasky Medical Center, Tel Aviv, Israel  Istituti Clinici Scientifici Maugeri IRCCS, Milan, Italy  London Health Sciences Centre, London, ON, Canada  NeuroSense Therapeutics, Herzliya, Israel  University Medical Center Utrecht, Utrecht, Netherlands  Tel Aviv University, Tel Aviv, Israel